Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q1 2026 Earnings

10MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.47

-0.32

-0.18

-0.03

Details

Expected EPS

-0.03

Actual EPS

-0.2

Surprise EPS

-0.17

Surprise Percent

+566.67%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.2 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.